Bacchus Vascular   Report issue

Contributed to NME For profit Phase 2
Founded: Santa Clara CA United States (1999)
Status: Acquired by Covidien (2009) → now Medtronic (2014)

Organization Overview

First Clinical Trial
2007
NCT00428129
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

ocriplasmin (jetrea) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Thrombosis (Phase 2)

Venous Thrombosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1